How many drugs treat Vitiligo?

Drug Landscape tracks 2 marketed treatments for Vitiligo (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/vitiligo.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Vitiligo — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitiligo (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Vitiligo, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Jakafi	RUXOLITINIB	Incyte Corp		Ankyrin repeat and protein kinase domain-containing protein 1, Bone morphogenetic protein receptor type-1B, Calcium/calmodulin-dependent protein kinase type IV		2011-01-01
Oxsoralen-Ultra	METHOXSALEN	Bausch Health	Photoactivated Radical Generator [EPC]	Cytochrome P450 1A2		1954-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Vitiligo
Bausch Health · 1 drug in Vitiligo
Incyte Corp · 1 drug in Vitiligo
Pfizer Inc. · 1 drug in Vitiligo

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Vitiligo:

Cite this brief

Drug Landscape (2026). Vitiligo — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/vitiligo. Accessed 2026-06-10.

Vitiligo full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing